Perioperative rates of incidental prostate cancer after aquablation and holmium laser enucleation of the prostate (HoLEP).


Journal

Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373

Informations de publication

Date de publication:
27 May 2024
Historique:
received: 01 02 2024
accepted: 03 04 2024
medline: 28 5 2024
pubmed: 28 5 2024
entrez: 27 5 2024
Statut: aheadofprint

Résumé

Aquablation and holmium laser enucleation of the prostate (HoLEP) have evolved as established therapeutic options for men with benign prostatic obstruction (BPO). To compare the rates of incidental carcinoma of the prostate (iPCa) after aquablation and HoLEP. At our center, between January 2020 and November 2022, 317 men underwent aquablation, and 979 men underwent HoLEP for BPO. Histopathological assessment of resected tissue was conducted in all cases. If iPCa was detected, the Gleason score and percentage of affected tissue were assessed. Differences in important predictive factors for prostate cancer between study groups were accounted for by additional matched pairs analysis (with matching on age ±1 year; PSA ±0.5 ng/ml; and prostate volume ±5 ml). Histopathology revealed iPCas in 60 patients (4.6%): 59 (6.03%) after HoLEP and 1 (0.3%) after aquablation (p=0.001). Of 60 of incidental cancers, 11 had a Gleason score ≥7 (aquablation: 1/1 (100%); HoLEP: 10/59 (16.9%)). The aquablation and HoLEP study groups differed in patient age, preoperative PSA and prostate volume. Therefore, matched pairs analysis (aquablation: 132 patients; HoLEP: 132 patients) was conducted to improve comparability. Also after the matching procedure, significantly fewer iPCas were diagnosed after aquablation than HoLEP (aquablation: 0 (0%); HoLEP: 6 (4.5%); p=0.015). Significantly fewer iPCas were identified after aquablation than HoLEP procedures. Histopathologic assessment of tissue after aquablation is feasible and may lead to the diagnosis of clinically significant iPCa. Therefore, histopathologic examination of the aquablation resective tissue should not be omitted. In patients who undergo surgery for benign prostatic enlargement, prostate cancer may be incidentally diagnosed on pathology. In this study, we looked at the rates of incidentally diagnosed prostate cancer of two different surgical procedures, laser enucleation of the prostate and aquablation.

Sections du résumé

BACKGROUND BACKGROUND
Aquablation and holmium laser enucleation of the prostate (HoLEP) have evolved as established therapeutic options for men with benign prostatic obstruction (BPO).
OBJECTIVE OBJECTIVE
To compare the rates of incidental carcinoma of the prostate (iPCa) after aquablation and HoLEP.
DESIGN, SETTING AND PARTICIPANTS METHODS
At our center, between January 2020 and November 2022, 317 men underwent aquablation, and 979 men underwent HoLEP for BPO. Histopathological assessment of resected tissue was conducted in all cases. If iPCa was detected, the Gleason score and percentage of affected tissue were assessed. Differences in important predictive factors for prostate cancer between study groups were accounted for by additional matched pairs analysis (with matching on age ±1 year; PSA ±0.5 ng/ml; and prostate volume ±5 ml).
RESULTS AND LIMITATIONS CONCLUSIONS
Histopathology revealed iPCas in 60 patients (4.6%): 59 (6.03%) after HoLEP and 1 (0.3%) after aquablation (p=0.001). Of 60 of incidental cancers, 11 had a Gleason score ≥7 (aquablation: 1/1 (100%); HoLEP: 10/59 (16.9%)). The aquablation and HoLEP study groups differed in patient age, preoperative PSA and prostate volume. Therefore, matched pairs analysis (aquablation: 132 patients; HoLEP: 132 patients) was conducted to improve comparability. Also after the matching procedure, significantly fewer iPCas were diagnosed after aquablation than HoLEP (aquablation: 0 (0%); HoLEP: 6 (4.5%); p=0.015).
CONCLUSIONS CONCLUSIONS
Significantly fewer iPCas were identified after aquablation than HoLEP procedures. Histopathologic assessment of tissue after aquablation is feasible and may lead to the diagnosis of clinically significant iPCa. Therefore, histopathologic examination of the aquablation resective tissue should not be omitted.
PATIENT SUMMARY RESULTS
In patients who undergo surgery for benign prostatic enlargement, prostate cancer may be incidentally diagnosed on pathology. In this study, we looked at the rates of incidentally diagnosed prostate cancer of two different surgical procedures, laser enucleation of the prostate and aquablation.

Identifiants

pubmed: 38801817
pii: 000539014
doi: 10.1159/000539014
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

The Author(s). Published by S. Karger AG, Basel.

Auteurs

Classifications MeSH